Nxera Pharma Co Ltd
TSE:4565
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nxera Pharma Co Ltd
TSE:4565
|
JP |
|
N
|
Nexity SA
XMUN:NQ9
|
FR |
|
G
|
Gem Resources PLC
LSE:GEMR
|
UK |
|
P
|
Pharos Energy PLC
SWB:OCS1
|
UK |
|
Adi Sarana Armada Tbk PT
IDX:ASSA
|
ID |
|
S
|
Sandoz Group AG
SIX:SDZ
|
CH |
|
Sunrise Shares Holdings Ltd
SGX:581
|
SG |
|
Engie SA
OTC:ENGQF
|
FR |
|
B
|
Bicycle Therapeutics PLC
SWB:50BA
|
UK |
|
C
|
Commerzbank AG
XHAM:CBK
|
DE |
|
B
|
Bridgestone Corp
OTC:BRDCF
|
JP |
|
F
|
Freeport-McMoRan Inc
DUS:FPMB
|
US |
|
L
|
Launch One Acquisition Corp
NASDAQ:LPAA
|
US |
|
D
|
DataDot Technology Ltd
ASX:DDT
|
AU |
Bankruptcy Probability
Nxera Pharma Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nxera Pharma Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
N
|
Nxera Pharma Co Ltd
TSE:4565
|
112.6B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nxera Pharma Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nxera Pharma Co Ltd has total debt of 47.7B JPY. This includes both short-term (777m JPY) and long-term (46.9B JPY) debt.
You can find a full breakdown on its Balance Sheet.